Descriptions

The autoinhibited protein was predicted that may have potential autoinhibitory elements via cis-regPred.

Autoinhibitory domains (AIDs)

Target domain

Relief mechanism

Assay

cis-regPred

Accessory elements

No accessory elements

Autoinhibited structure

Activated structure

3 structures for O60353

Entry ID Method Resolution Chain Position Source
8JH7 EM 320 A PDB
8JHB EM 330 A R 19-525 PDB
AF-O60353-F1 Predicted AlphaFoldDB

517 variants for O60353

Variant ID(s) Position Change Description Diseaes Association Provenance
COSM1453720
rs981045005
RCV000593548
RCV001027647
CA182984555
96 R>C Variant assessed as Somatic; 0.0 impact. large_intestine Nonsyndromic congenital nail disorder 1 [NCI-TCGA, Cosmic, ClinVar] Yes ClinGen
cosmic curated
ClinVar
NCI-TCGA
dbSNP
gnomAD
CA4834765
RCV000578928
rs769116796
RCV000505681
116 R>* Nephroblastoma [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
RCV000170581
rs786205672
RCV001329712
CA199714
290 Y>C Non-immune hydrops fetalis Nonsyndromic congenital nail disorder 1 [ClinVar] Yes ClinGen
ClinVar
Ensembl
dbSNP
RCV000988106
VAR_066966
rs150760762
CA4834902
405 R>Q Nonsyndromic congenital nail disorder 1 [ClinVar] Yes ClinGen
ClinVar
UniProt
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs1371244150
RCV001027648
CA371620487
438 E>K Nonsyndromic congenital nail disorder 1 [ClinVar] Yes ClinGen
ClinVar
TOPMed
dbSNP
CA4834966
rs766284226
RCV001027646
509 R>* Nonsyndromic congenital nail disorder 1 [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
RCV000077801
CA129147
rs151339003
VAR_066398
RCV000023301
511 R>C Nail disease Nonsyndromic congenital nail disorder 1 NDNC1; also found in a patient with neural tube defects; the mutant protein localizes to the lysosomes compared to wild-type [ClinVar, UniProt] Yes ClinGen
ClinVar
UniProt
ExAC
TOPMed
dbSNP
gnomAD
rs151339002
RCV000077802
RCV000023300
CA129144
584 E>* Nail disease Nonsyndromic congenital nail disorder 1 [ClinVar] Yes ClinGen
ClinVar
ExAC
TOPMed
dbSNP
gnomAD
CA371649986
CA371649985
rs3736047
2 E>D No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1210913676
CA371649983
2 E>G No ClinGen
gnomAD
CA371649994
rs1210122452
3 M>I No ClinGen
TOPMed
rs748362787
CA4834687
3 M>V No ClinGen
ExAC
gnomAD
rs1331820142
CA371650000
4 F>C No ClinGen
TOPMed
rs1223505061
CA371650009
6 F>I No ClinGen
TOPMed
rs754581593
CA4834690
9 T>M Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
CA371650037
rs1198557940
10 C>G No ClinGen
gnomAD
rs770928662
CA4834691
11 I>F No ClinGen
ExAC
TCGA novel 11 I>V Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA371650066
rs1428125576
14 P>L No ClinGen
gnomAD
rs774093482
CA4834692
15 L>I No ClinGen
ExAC
gnomAD
rs117477069
CA4834693
16 L>V No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs372702981
CA4834695
20 S>C No ClinGen
ESP
ExAC
gnomAD
CA371650101
rs375688505
20 S>N No ClinGen
ESP
gnomAD
CA182981276
rs375688505
20 S>T No ClinGen
ESP
gnomAD
rs760374585
CA4834696
23 T>I No ClinGen
ExAC
gnomAD
rs150839394
CA4834699
29 V>F No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs150839394
CA371650160
29 V>I No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1214604944
CA371650173
31 R>K No ClinGen
TOPMed
gnomAD
rs568034251
CA371650177
31 R>S No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA371650182
rs752048729
32 C>F No ClinGen
ExAC
TOPMed
gnomAD
CA4834701
rs752048729
32 C>Y No ClinGen
ExAC
TOPMed
gnomAD
rs374556380
CA4834703
33 M>I No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs827528
CA182981286
33 M>L No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA4834702
rs827528
VAR_047440
33 M>V No ClinGen
UniProt
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA182981289
rs970993467
34 K>Q No ClinGen
TOPMed
rs111920622
CA182981291
34 K>T No ClinGen
TOPMed
CA371650208
rs1463161138
36 A>S No ClinGen
TOPMed
CA4834704
rs752962628
38 N>S No ClinGen
ExAC
TOPMed
gnomAD
rs1322899571
CA371650231
39 M>T No ClinGen
TOPMed
rs1183370179
CA371650228
39 M>V No ClinGen
Ensembl
CA371650255
rs1292467728
42 F>S Variant assessed as Somatic; impact. [NCI-TCGA] No ClinGen
NCI-TCGA
TOPMed
rs553335677
CA4834705
44 N>S No ClinGen
1000Genomes
ExAC
gnomAD
TCGA novel 46 M>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1360566064
CA371650285
47 G>S No ClinGen
gnomAD
CA4834707
rs777814122
48 H>L No ClinGen
ExAC
gnomAD
CA371650319
rs1300823391
51 Q>R No ClinGen
gnomAD
rs753953103
CA4834708
52 S>G No ClinGen
ExAC
gnomAD
rs757230055
CA4834709
52 S>N No ClinGen
ExAC
gnomAD
rs779056600
CA4834710
53 I>S No ClinGen
ExAC
TOPMed
gnomAD
rs1348502085
CA371650329
53 I>V No ClinGen
gnomAD
rs1298616697
CA371650340
55 A>T No ClinGen
TOPMed
CA4834711
rs571735437
55 A>V No ClinGen
1000Genomes
ExAC
gnomAD
TCGA novel 57 E>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA371650391
rs780099524
60 H>D No ClinGen
ExAC
TOPMed
gnomAD
rs780099524
CA4834736
60 H>Y No ClinGen
ExAC
TOPMed
gnomAD
rs146283758
CA4834737
61 F>S No ClinGen
ESP
ExAC
gnomAD
rs1487776894
CA371650418
64 L>F No ClinGen
gnomAD
rs375098302
CA4834740
65 A>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA371650452
rs1563689931
69 C>S No ClinGen
Ensembl
rs762407732
CA4834743
71 P>L Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
TCGA novel 72 N>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA4834744
rs772568156
73 I>F No ClinGen
ExAC
gnomAD
CA4834745
rs775914993
73 I>T No ClinGen
ExAC
gnomAD
CA371650475
rs772568156
73 I>V No ClinGen
ExAC
gnomAD
CA371650518
rs1357409316
79 K>E No ClinGen
TOPMed
rs1287392567
CA371650539
82 V>L No ClinGen
TOPMed
gnomAD
rs1049206443
CA182984546
85 C>Y No ClinGen
TOPMed
CA371650563
rs776955040
86 I>L No ClinGen
ExAC
TOPMed
gnomAD
CA4834748
rs776955040
86 I>V No ClinGen
ExAC
TOPMed
gnomAD
CA4834749
rs761922015
88 Q>E No ClinGen
ExAC
TOPMed
gnomAD
rs943636809
CA182984550
88 Q>P No ClinGen
TOPMed
CA4834750
rs765509501
92 V>L No ClinGen
ExAC
TOPMed
gnomAD
rs534988999
CA4834752
94 P>L No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA4834751
rs750564903
94 P>S No ClinGen
ExAC
gnomAD
CA4834753
rs766434022
96 R>H No ClinGen
ExAC
TOPMed
gnomAD
CA371650635
rs1487285963
97 K>R No ClinGen
gnomAD
rs1267735158
CA371650640
98 L>F No ClinGen
gnomAD
CA4834755
rs754842098
98 L>H No ClinGen
ExAC
gnomAD
CA4834756
rs780825596
99 C>R No ClinGen
ExAC
gnomAD
CA4834757
rs747924397
100 E>* No ClinGen
ExAC
gnomAD
rs755791699
CA4834758
100 E>G No ClinGen
ExAC
gnomAD
CA371650663
rs748806283
101 K>N No ClinGen
ExAC
gnomAD
rs777335863
CA4834759
101 K>R No ClinGen
ExAC
gnomAD
rs1415526913
CA371650697
104 S>F No ClinGen
TOPMed
TCGA novel 109 L>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 109 L>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA4834762
rs770418746
109 L>V No ClinGen
ExAC
TOPMed
gnomAD
CA4834763
rs776136233
110 I>F No ClinGen
ExAC
gnomAD
CA371650795
rs1586517286
110 I>M No ClinGen
Ensembl
CA182984567
rs1033835463
110 I>T No ClinGen
Ensembl
rs952870905
CA182984569
112 T>N No ClinGen
TOPMed
gnomAD
CA4834764
rs747445291
115 I>S No ClinGen
ExAC
TOPMed
gnomAD
CA371650881
rs1466686516
116 R>Q No ClinGen
TOPMed
rs760023367
CA4834766
117 W>R No ClinGen
ExAC
TOPMed
gnomAD
rs762230921
CA4834767
120 E>D No ClinGen
ExAC
gnomAD
rs1452349213
CA371650958
121 L>I No ClinGen
TOPMed
rs939650828
CA182984577
122 E>A No ClinGen
TOPMed
gnomAD
rs1319580028
CA371650974
122 E>Q No ClinGen
gnomAD
rs765560923
CA4834768
124 D>G No ClinGen
ExAC
TOPMed
gnomAD
rs149943553
CA182544632
127 Q>R No ClinGen
ESP
TOPMed
gnomAD
rs371495168
CA4834793
129 C>* No ClinGen
ESP
ExAC
gnomAD
CA4834792
rs767365157
129 C>G No ClinGen
ExAC
gnomAD
rs760533281
CA4834794
130 D>E No ClinGen
ExAC
TOPMed
gnomAD
rs1466609347
CA371615816
130 D>G No ClinGen
gnomAD
rs1397980291
CA371615828
132 T>A No ClinGen
TOPMed
rs564497180
CA4834795
133 V>A No ClinGen
1000Genomes
ExAC
gnomAD
rs935109876
CA182544733
134 P>A No ClinGen
gnomAD
rs1052086135
CA182544737
136 T>I No ClinGen
Ensembl
TCGA novel 137 F>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA4834796
rs377272890
137 F>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA4834797
rs80216383
VAR_066963
140 H>Y No ClinGen
UniProt
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
TCGA novel 144 L>missing Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs749906371
CA4834799
146 P>L No ClinGen
ExAC
TOPMed
gnomAD
CA4834798
rs778588461
146 P>S No ClinGen
ExAC
gnomAD
rs768203511
CA4834800
148 K>E No ClinGen
ExAC
gnomAD
CA371616056
rs1276485475
148 K>T No ClinGen
TOPMed
gnomAD
rs1438660101
CA371616077
149 K>I No ClinGen
TOPMed
TCGA novel 150 T>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 151 E>* Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA4834801
rs781609213
151 E>D No ClinGen
ExAC
TOPMed
gnomAD
rs1310126701
CA371616131
151 E>V No ClinGen
TOPMed
gnomAD
VAR_066964
CA4834802
rs61753730
152 Q>E No ClinGen
UniProt
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs1486796562
CA371616167
153 V>G No ClinGen
gnomAD
CA4834803
rs770330304
153 V>I No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 155 R>K Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA4834805
rs749629030
156 D>H No ClinGen
ExAC
gnomAD
TCGA novel 156 D>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1563692260
CA371616266
158 G>V No ClinGen
Ensembl
CA4834806
rs771059227
162 P>A No ClinGen
ExAC
gnomAD
rs1170004620
CA371616340
162 P>L No ClinGen
gnomAD
CA371616341
rs1414381279
163 R>G No ClinGen
gnomAD
rs1563692306
CA371616350
163 R>S No ClinGen
Ensembl
rs774570399
CA4834807
164 H>R No ClinGen
ExAC
TOPMed
gnomAD
rs928048347
CA182544805
165 L>F No ClinGen
TOPMed
rs1563692320
CA371616383
165 L>P No ClinGen
Ensembl
CA4834809
rs772185760
168 S>P No ClinGen
ExAC
CA4834812
CA4834811
rs529849844
169 G>R No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA371616441
rs753667894
170 G>A No ClinGen
ExAC
gnomAD
rs753667894
CA371616439
170 G>E No ClinGen
ExAC
gnomAD
rs753667894
CA4834813
170 G>V No ClinGen
ExAC
gnomAD
rs376449974
CA182544858
171 Q>R No ClinGen
ESP
rs548106295
CA182544869
173 Y>C No ClinGen
1000Genomes
TOPMed
gnomAD
rs764810706
CA4834815
174 K>E No ClinGen
ExAC
gnomAD
CA182544888
rs1027272168
174 K>R No ClinGen
Ensembl
rs750079022
CA4834816
176 L>R No ClinGen
ExAC
gnomAD
rs1219701399
CA371616574
177 G>R No ClinGen
gnomAD
rs142125344
CA182544904
179 D>N No ClinGen
ESP
CA4834817
rs757914216
181 C>S No ClinGen
ExAC
gnomAD
rs147788385
CA4834818
182 A>T No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
CA4834819
rs751062369
182 A>V No ClinGen
ExAC
TOPMed
gnomAD
rs778357612
CA4834821
187 N>S No ClinGen
ExAC
gnomAD
rs931241044
CA182544924
188 M>T No ClinGen
TOPMed
rs749679944
CA4834822
190 F>L No ClinGen
ExAC
gnomAD
CA4834823
rs771311097
193 D>H No ClinGen
ExAC
gnomAD
rs779068115
CA4834824
193 D>V No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 194 E>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1210328421
CA371616908
195 L>P No ClinGen
gnomAD
rs1396374934
CA371616934
196 E>G No ClinGen
gnomAD
rs746074508
CA4834825
197 F>S No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 199 K>E Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs775573797
CA4834828
202 I>S No ClinGen
ExAC
TOPMed
gnomAD
CA4834827
rs775573797
202 I>T No ClinGen
ExAC
TOPMed
gnomAD
CA182544966
CA371617060
rs1048279178
203 G>R No ClinGen
TOPMed
rs776494531
CA4834830
207 I>M No ClinGen
ExAC
gnomAD
rs146924761
CA4834829
207 I>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA371617159
rs1330234377
208 F>C No ClinGen
TOPMed
gnomAD
CA371617156
rs1330234377
208 F>S No ClinGen
TOPMed
gnomAD
CA371617161
rs1330234377
208 F>Y No ClinGen
TOPMed
gnomAD
TCGA novel 209 C>Y Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1437126989
CA371617211
210 L>F No ClinGen
gnomAD
rs1279554917
CA371617218
210 L>P No ClinGen
TOPMed
rs1352592850
CA371617252
212 A>E No ClinGen
TOPMed
CA371617303
rs1237966129
216 T>A No ClinGen
TOPMed
CA371617308
rs1563692486
216 T>I No ClinGen
Ensembl
CA4834832
rs765077597
217 F>C No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 219 T>P Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA182545005
CA371617405
rs893947591
221 L>* No ClinGen
TOPMed
rs1351700529
CA371617419
222 I>V No ClinGen
gnomAD
CA371617497
rs1586524226
225 R>I No ClinGen
Ensembl
CA182545007
rs1029258122
231 E>K No ClinGen
Ensembl
rs751119249
CA4834836
236 Y>C No ClinGen
ExAC
CA4834835
rs372850452
236 Y>H No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs754477513
CA4834838
237 Y>C No ClinGen
ExAC
TOPMed
TCGA novel 241 Y>C Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA371617819
rs1194639978
242 S>N No ClinGen
gnomAD
rs1255516559
CA371617844
243 I>T No ClinGen
gnomAD
rs1453378750
CA371617855
244 V>A No ClinGen
TOPMed
rs879007257
CA182545037
245 S>T No ClinGen
Ensembl
rs764751010
CA4834840
246 L>F No ClinGen
ExAC
gnomAD
CA371617865
rs764751010
246 L>V No ClinGen
ExAC
gnomAD
rs377161583
CA4834841
247 M>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs757599522
CA4834842
249 F>L No ClinGen
ExAC
gnomAD
CA371617918
rs1161041099
250 I>M No ClinGen
gnomAD
rs1470963015
CA371617916
250 I>T No ClinGen
gnomAD
CA371617919
rs1389553987
251 G>R No ClinGen
gnomAD
TCGA novel 252 F>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA371617936
rs1176717343
252 F>Y No ClinGen
gnomAD
rs1327634438
CA371617946
253 L>F No ClinGen
gnomAD
rs1445893196
CA371617953
255 G>S No ClinGen
gnomAD
COSM1094460
rs201820118
CA4834845
256 D>N Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
CA371617968
rs1241465064
257 S>G No ClinGen
gnomAD
TCGA novel 259 A>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1178027003
CA371617981
259 A>T No ClinGen
gnomAD
CA4834846
rs780187587
261 N>S No ClinGen
ExAC
gnomAD
rs1355903108
CA371618004
262 K>* No ClinGen
gnomAD
rs1214749440
CA371618006
262 K>R No ClinGen
gnomAD
CA371618031
rs1448517780
COSM453773
265 E>D breast [Cosmic] No ClinGen
cosmic curated
TOPMed
rs1193820321
CA371618024
265 E>K No ClinGen
TOPMed
CA371618037
rs1281963730
266 K>M No ClinGen
TOPMed
CA4834847
rs747106870
269 L>R No ClinGen
ExAC
gnomAD
CA371618068
rs1563692618
271 D>G No ClinGen
Ensembl
rs1204165688
CA371618074
272 T>A No ClinGen
TOPMed
rs776618074
CA4834849
274 V>L No ClinGen
ExAC
TOPMed
gnomAD
rs370601506
CA4834851
277 S>C No ClinGen
ESP
ExAC
gnomAD
rs375091015
CA4834852
281 A>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs762587938
CA4834853
282 C>Y No ClinGen
ExAC
gnomAD
rs766142758
CA371618142
283 T>A No ClinGen
ExAC
gnomAD
rs766142758
CA4834854
283 T>S No ClinGen
ExAC
gnomAD
rs141253426
CA4834855
284 V>I Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
1000Genomes
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1412160705
CA371618161
286 F>Y No ClinGen
Ensembl
CA371618170
rs1398525123
287 M>T No ClinGen
gnomAD
TCGA novel 292 F>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 293 T>H Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA4834856
rs759181459
293 T>I No ClinGen
ExAC
TOPMed
gnomAD
rs1357610731
CA371618223
294 M>I No ClinGen
gnomAD
CA4834857
rs767102317
294 M>L No ClinGen
ExAC
gnomAD
CA371618220
rs1234072800
294 M>T No ClinGen
gnomAD
CA371618229
rs1316728046
295 A>V No ClinGen
TOPMed
rs1295529759
CA371618230
296 G>S No ClinGen
gnomAD
rs1586524678
CA371618237
297 T>A No ClinGen
Ensembl
rs754354607
CA4834858
299 W>* No ClinGen
ExAC
TOPMed
gnomAD
rs754354607
CA4834859
299 W>S No ClinGen
ExAC
TOPMed
gnomAD
rs1218401052
CA371618261
300 W>* No ClinGen
gnomAD
rs1586524699
CA371618257
300 W>G No ClinGen
Ensembl
rs1586524720
CA371618269
301 V>G No ClinGen
Ensembl
CA371618271
rs1586524741
302 I>V No ClinGen
Ensembl
CA371618281
rs1469541628
303 L>P No ClinGen
gnomAD
TCGA novel 304 T>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
TCGA novel 308 F>L Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1563692714
CA371618314
308 F>Y No ClinGen
Ensembl
rs1254810955
CA371618322
309 L>S No ClinGen
gnomAD
CA371618332
rs1459882979
311 A>T No ClinGen
TOPMed
rs758705643
CA4834862
312 G>R No ClinGen
ExAC
gnomAD
CA371618343
rs1413255088
313 R>G No ClinGen
TOPMed
rs1168415461
CA371618345
313 R>K No ClinGen
TOPMed
rs138895095
CA182545293
317 C>Y No ClinGen
ESP
TOPMed
rs747229738
CA4834864
319 A>T No ClinGen
ExAC
gnomAD
CA4834866
rs536022156
321 E>K Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
1000Genomes
ExAC
NCI-TCGA
TOPMed
gnomAD
rs748134351
CA4834867
322 Q>* No ClinGen
ExAC
gnomAD
CA182545342
rs1048216110
322 Q>R No ClinGen
Ensembl
CA371618424
rs1464461855
324 A>P No ClinGen
gnomAD
rs769774212
CA182545359
325 V>A No ClinGen
ExAC
TOPMed
gnomAD
rs769774212
CA4834868
325 V>E No ClinGen
ExAC
TOPMed
gnomAD
CA371618447
rs1374882408
327 F>Y No ClinGen
gnomAD
rs144742285
CA4834869
329 A>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA4834872
rs770841418
332 W>* No ClinGen
ExAC
TOPMed
gnomAD
CA4834871
rs770841418
332 W>C No ClinGen
ExAC
TOPMed
gnomAD
rs1399829071
CA371618490
334 T>A No ClinGen
gnomAD
rs1296713082
CA371618509
336 G>R No ClinGen
gnomAD
rs1004883584
CA371619052
337 F>L No ClinGen
TOPMed
gnomAD
rs771804340
CA4834875
340 V>I No ClinGen
ExAC
gnomAD
rs1215635668
CA371619105
341 M>I No ClinGen
TOPMed
rs191400696
CA4834877
341 M>R No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
rs191400696
CA4834876
341 M>T No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA4834878
rs3808553
VAR_047441
345 M>L No ClinGen
UniProt
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA4834879
rs371618519
345 M>T No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA371619136
rs3808553
345 M>V No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs763375328
CA4834880
347 K>E No ClinGen
ExAC
gnomAD
TCGA novel 347 K>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1263522296
CA371619183
348 V>A No ClinGen
gnomAD
rs766701271
CA182545467
350 G>E No ClinGen
ExAC
gnomAD
CA4834881
rs766701271
350 G>V No ClinGen
ExAC
gnomAD
CA371619209
rs1328172302
351 D>H No ClinGen
TOPMed
CA371619215
rs1197995078
351 D>V No ClinGen
gnomAD
TCGA novel 352 N>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA371619227
rs1439059082
352 N>I No ClinGen
TOPMed
rs1439059082
CA371619223
352 N>S No ClinGen
TOPMed
rs751829856
CA4834882
357 C>S No ClinGen
ExAC
gnomAD
CA4834883
rs142793974
367 S>F No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1563692945
CA371619385
367 S>P No ClinGen
Ensembl
rs374264909
CA4834884
368 R>C No ClinGen
ExAC
TOPMed
gnomAD
rs374264909
CA371619395
368 R>G No ClinGen
ExAC
TOPMed
gnomAD
rs375068426
CA4834885
368 R>H Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA182545588
rs375068426
368 R>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA371619441
rs1289852576
372 L>F No ClinGen
gnomAD
CA4834886
rs756134702
372 L>P No ClinGen
ExAC
gnomAD
rs1385607524
CA371619468
374 P>S No ClinGen
gnomAD
CA4834889
rs770896684
377 L>F No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 377 L>I Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1283232121
CA371619517
379 V>M No ClinGen
gnomAD
CA4834890
rs374209572
381 V>I No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA4834891
rs745621688
384 S>C No ClinGen
ExAC
gnomAD
CA371619585
rs745621688
384 S>F No ClinGen
ExAC
gnomAD
CA4834892
rs558172378
385 L>I No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA4834893
VAR_066965
rs142694816
388 A>D No ClinGen
UniProt
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
TCGA novel 389 G>D Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA182545617
rs1032475511
392 S>F No ClinGen
Ensembl
CA371619761
rs776411650
395 H>L No ClinGen
gnomAD
CA182545637
rs776411650
395 H>R No ClinGen
gnomAD
CA371619751
rs1586525320
395 H>Y No ClinGen
Ensembl
CA371619768
rs1378512583
396 V>F No ClinGen
gnomAD
CA4834895
rs768048309
397 R>* No ClinGen
ExAC
gnomAD
CA4834896
rs773811711
COSM1094463
397 R>Q Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
CA4834898
rs766830082
398 Q>R No ClinGen
ExAC
TOPMed
gnomAD
CA371619810
rs1205160632
399 V>I No ClinGen
TOPMed
CA371619906
rs1325611528
403 D>H No ClinGen
gnomAD
rs186016315
CA4834901
405 R>W Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
1000Genomes
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA371620073
rs1280383857
414 M>I No ClinGen
TOPMed
rs1367124305
CA371620052
414 M>V No ClinGen
TOPMed
rs370982279
CA4834903
415 I>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA4834904
rs777689471
416 R>* Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
gnomAD
CA4834905
rs763949530
COSM421803
416 R>Q Variant assessed as Somatic; 0.0 impact. large_intestine endometrium urinary_tract [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
TOPMed
gnomAD
CA182545735
rs745581835
417 I>T No ClinGen
Ensembl
CA4834906
rs757294301
419 V>D No ClinGen
ExAC
TOPMed
gnomAD
CA371620139
rs757294301
419 V>G No ClinGen
ExAC
TOPMed
gnomAD
rs376142293
CA4834908
422 G>S No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs779823367
CA4834910
423 L>F No ClinGen
ExAC
gnomAD
CA371620196
rs1236450328
423 L>S No ClinGen
gnomAD
CA4834912
rs746611504
424 Y>C No ClinGen
ExAC
TOPMed
gnomAD
CA4834911
rs746611504
424 Y>F No ClinGen
ExAC
TOPMed
gnomAD
rs1432404440
CA371620209
424 Y>H No ClinGen
TOPMed
CA371620252
rs1422261267
426 V>L No ClinGen
gnomAD
CA371620255
rs1422261267
426 V>M No ClinGen
gnomAD
TCGA novel 427 P>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs952688049
CA182545773
430 T>I No ClinGen
TOPMed
CA371620350
rs1182066631
431 L>V No ClinGen
TOPMed
CA4834914
rs541992719
433 G>R Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
1000Genomes
ExAC
NCI-TCGA
TOPMed
gnomAD
rs756849567
CA4834915
434 C>F No ClinGen
ExAC
TOPMed
gnomAD
CA4834917
rs759960644
436 V>I No ClinGen
ExAC
gnomAD
rs560116992
CA4834921
440 V>A No ClinGen
1000Genomes
ExAC
gnomAD
CA4834920
rs760826071
440 V>M No ClinGen
ExAC
gnomAD
CA4834922
rs753974488
442 R>G No ClinGen
ExAC
TOPMed
gnomAD
rs753974488
CA371620569
442 R>W No ClinGen
ExAC
TOPMed
gnomAD
rs1336606160
CA371620637
445 W>* No ClinGen
gnomAD
CA371620654
rs1278481298
446 E>G No ClinGen
gnomAD
CA4834923
rs757357454
447 I>T No ClinGen
ExAC
gnomAD
rs1319324841
CA371620733
450 V>A No ClinGen
gnomAD
CA182545855
rs527378976
450 V>F No ClinGen
1000Genomes
CA371620761
rs1415509621
452 D>E No ClinGen
TOPMed
TCGA novel 453 H>Q Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs764886770
CA371620806
454 C>* No ClinGen
gnomAD
rs1272285096
CA371620802
454 C>F No ClinGen
gnomAD
rs368015730
CA4834924
455 R>C Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
CA182545880
rs551894404
455 R>H No ClinGen
1000Genomes
TOPMed
rs963976545
CA182545894
459 I>V No ClinGen
TOPMed
rs1271758222
CA371620928
461 C>R No ClinGen
gnomAD
CA371620960
rs1398645999
462 P>T No ClinGen
TOPMed
CA371621000
rs1187402604
464 Q>E No ClinGen
gnomAD
rs779693042
CA4834927
464 Q>H No ClinGen
ExAC
gnomAD
rs1286940633
CA4834942
465 A>G No ClinGen
TOPMed
CA4834944
rs765376606
467 A>S No ClinGen
ExAC
gnomAD
rs1188744886
CA371621491
469 A>D No ClinGen
gnomAD
CA4834945
rs750436184
470 R>* Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
COSM1094465
rs758292286
CA4834946
470 R>Q Variant assessed as Somatic; 0.0 impact. endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ExAC
NCI-TCGA
gnomAD
rs147565570
CA4834949
472 E>G No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs751323317
CA4834948
472 E>Q No ClinGen
ExAC
TOPMed
gnomAD
rs1432819906
CA371621628
474 A>V No ClinGen
gnomAD
CA182548359
rs768721252
477 M>K No ClinGen
TOPMed
rs777284498
CA4834953
478 I>M No ClinGen
ExAC
gnomAD
CA4834955
rs149021436
480 Y>* No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs376124026
CA4834957
485 I>S No ClinGen
ESP
ExAC
gnomAD
CA4834958
rs780555971
486 V>F No ClinGen
ExAC
gnomAD
rs747394243
CA4834959
488 I>S No ClinGen
ExAC
gnomAD
rs769142373
CA4834960
489 S>T No ClinGen
ExAC
gnomAD
CA4834964
rs773197811
493 W>C No ClinGen
ExAC
gnomAD
CA4834963
rs770093420
COSM3675025
493 W>L prostate [Cosmic] No ClinGen
cosmic curated
ExAC
gnomAD
rs113688012
CA182548483
494 V>A No ClinGen
Ensembl
TCGA novel 498 K>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs1468284989
CA371622413
498 K>Q No ClinGen
TOPMed
gnomAD
rs1414701442
CA371622541
504 A>T No ClinGen
TOPMed
gnomAD
CA371622730
rs1385205122
508 K>* No ClinGen
gnomAD
CA371622753
rs766284226
509 R>G No ClinGen
ExAC
TOPMed
gnomAD
CA4834967
rs143405641
COSM1094468
509 R>Q Variant assessed as Somatic; 0.0 impact. large_intestine endometrium [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
rs1393674469
CA371622782
510 N>T No ClinGen
gnomAD
rs767273753
CA4834968
VAR_066967
511 R>H Variant assessed as Somatic; 0.0 impact. a patient with neural tube defects [NCI-TCGA, UniProt] No ClinGen
UniProt
ExAC
NCI-TCGA
dbSNP
gnomAD
rs1236956669
CA371622842
512 K>N No ClinGen
gnomAD
rs761539526
CA4834969
514 D>G No ClinGen
ExAC
TOPMed
gnomAD
rs1291827455
CA371624430
515 P>L No ClinGen
gnomAD
rs1032747700
CA182549730
516 I>V No ClinGen
TOPMed
rs1271354824
CA371624447
517 S>C No ClinGen
TOPMed
CA4834985
rs759490885
519 S>T No ClinGen
ExAC
TOPMed
gnomAD
CA4834986
rs151317643
520 R>* No ClinGen
ESP
ExAC
gnomAD
CA182549785
rs367925897
520 R>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA371624479
rs367925897
520 R>P No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA4834987
rs367925897
520 R>Q No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs140569835
CA4834989
522 V>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA182549802
rs866038097
524 Q>K No ClinGen
Ensembl
rs1439202689
CA371624522
524 Q>R No ClinGen
gnomAD
CA4834990
rs753526077
525 E>Q No ClinGen
ExAC
gnomAD
rs756757913
CA4834991
527 C>R No ClinGen
ExAC
gnomAD
rs1475451914
CA371624564
527 C>W No ClinGen
gnomAD
CA371624632
rs1166790169
532 K>N No ClinGen
TOPMed
gnomAD
CA4834992
rs764786532
534 N>H No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 536 K>E Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA4834994
rs554970152
544 Y>C No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA182549883
rs1021765095
547 S>G No ClinGen
TOPMed
CA371624794
rs1431877722
547 S>N No ClinGen
gnomAD
CA4834995
rs375398057
549 H>Y No ClinGen
ESP
ExAC
gnomAD
rs1415822378
CA371624824
550 K>Q No ClinGen
gnomAD
TCGA novel 552 K>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA182549947
rs748578409
553 V>A No ClinGen
ExAC
gnomAD
rs748578409
CA4834996
553 V>D No ClinGen
ExAC
gnomAD
CA371624869
rs1325234560
554 I>T No ClinGen
gnomAD
CA4834997
rs756540473
555 S>C No ClinGen
ExAC
gnomAD
rs145774645
CA4834998
557 S>F Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ESP
ExAC
NCI-TCGA
TOPMed
gnomAD
CA371624909
rs1208095664
558 M>L No ClinGen
TOPMed
gnomAD
rs1208095664
CA371624907
558 M>V No ClinGen
TOPMed
gnomAD
rs1279212971
CA371624945
561 S>N No ClinGen
TOPMed
gnomAD
CA4834999
rs749500056
566 A>E No ClinGen
ExAC
gnomAD
rs1160809849
CA371625018
568 H>P No ClinGen
gnomAD
rs1160809849
COSM1285090
CA371625019
568 H>R autonomic_ganglia Variant assessed as Somatic; impact. [Cosmic, NCI-TCGA] No ClinGen
cosmic curated
NCI-TCGA
gnomAD
CA371625052
rs1259349680
572 A>T No ClinGen
gnomAD
rs745879785
CA4835002
575 I>V No ClinGen
ExAC
gnomAD
TCGA novel 576 T>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA4835004
rs775395889
578 H>R Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
ExAC
NCI-TCGA
TOPMed
gnomAD
rs760532855
CA4835005
582 G>E No ClinGen
ExAC
gnomAD
rs776196559
CA4835007
583 Q>R No ClinGen
ExAC
gnomAD
CA182550045
rs151339002
584 E>K No ClinGen
ExAC
TOPMed
gnomAD
rs1339133281
CA371625195
585 T>A No ClinGen
TOPMed
TCGA novel 585 T>N Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
rs764759728
CA4835008
586 L>S No ClinGen
ExAC
gnomAD
CA371625225
rs1231505920
588 E>* No ClinGen
TOPMed
gnomAD
rs1231505920
CA371625222
588 E>K No ClinGen
TOPMed
gnomAD
CA371625249
rs1359184533
590 Q>* No ClinGen
TOPMed
gnomAD
rs1347605213
CA371625263
591 T>N No ClinGen
TOPMed
rs963229485
CA182550070
595 T>I No ClinGen
gnomAD
rs1485454569
CA371625333
598 R>* No ClinGen
gnomAD
rs758708176
CA371625349
599 E>D No ClinGen
ExAC
TOPMed
gnomAD
rs1355142337
CA371625343
599 E>K No ClinGen
TOPMed
CA371625354
rs1381945857
600 V>L No ClinGen
TOPMed
gnomAD
CA371625351
rs1381945857
600 V>M No ClinGen
TOPMed
gnomAD
rs556352002
CA4835011
602 A>V No ClinGen
ExAC
TOPMed
gnomAD
rs79408516
CA4835014
VAR_066968
604 G>R No ClinGen
UniProt
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs749576044
CA4835015
607 T>A No ClinGen
ExAC
gnomAD
CA4835016
rs757505339
607 T>N No ClinGen
ExAC
gnomAD
CA371625440
rs749576044
607 T>P No ClinGen
ExAC
gnomAD
rs143153183
CA4835019
609 R>K No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs1040321851
CA371625491
CA182550154
609 R>S No ClinGen
TOPMed
gnomAD
TCGA novel 610 L>S Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA371625538
rs1324637196
611 R>S No ClinGen
gnomAD
rs1586531763
CA371625607
613 Q>H No ClinGen
Ensembl
rs746927610
CA4835022
614 D>H No ClinGen
ExAC
gnomAD
CA4835021
rs746927610
614 D>N No ClinGen
ExAC
gnomAD
rs377263981
CA4835023
615 C>S No ClinGen
ESP
ExAC
gnomAD
CA371625670
rs1444393939
615 C>S No ClinGen
gnomAD
rs1586531802
CA371625712
617 E>D No ClinGen
Ensembl
CA4835025
rs138824850
618 P>L No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA371625741
rs138824850
618 P>R No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs903082125
CA182550260
619 A>V No ClinGen
TOPMed
CA4835027
rs762588534
620 S>L No ClinGen
ExAC
gnomAD
CA4835026
VAR_066969
rs116195528
620 S>T No ClinGen
UniProt
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
rs751060280
CA4835029
622 A>G No ClinGen
ExAC
gnomAD
CA4835030
rs144179120
623 A>V No ClinGen
ESP
ExAC
gnomAD
CA371625860
rs1192966381
625 I>V Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA4835033
rs754241636
629 S>A No ClinGen
ExAC
gnomAD
CA4835034
rs757546452
630 G>A No ClinGen
ExAC
TOPMed
gnomAD
rs1164898443
CA371626006
631 E>Q No ClinGen
gnomAD
CA4835035
rs779174548
631 E>V No ClinGen
ExAC
gnomAD
rs750613302
CA4835036
632 Q>* No ClinGen
ExAC
gnomAD
rs758522857
CA4835037
633 V>I No ClinGen
ExAC
gnomAD
CA371626086
rs139052958
634 D>H No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA4835039
rs139052958
634 D>N No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA4835041
rs116913901
635 G>R No ClinGen
1000Genomes
ExAC
TOPMed
gnomAD
CA371626203
rs1173573170
639 A>G No ClinGen
gnomAD
rs1175129726
CA371626202
639 A>T No ClinGen
TOPMed
CA4835043
rs769442423
641 S>N No ClinGen
ExAC
gnomAD
CA371626291
rs1419232323
644 E>A No ClinGen
TOPMed
CA371626331
rs1323413408
645 S>G No ClinGen
gnomAD
CA371626341
rs371961225
645 S>I No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA4835044
rs371961225
645 S>N No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1456980766
CA371626344
645 S>R No ClinGen
TOPMed
rs141288802
CA371626364
646 A>G No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1231211711
CA371626347
646 A>T No ClinGen
TOPMed
gnomAD
rs141288802
CA4835045
646 A>V No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs768811178
CA4835047
647 R>Q No ClinGen
ExAC
TOPMed
gnomAD
CA182550428
COSM1488857
rs201432167
647 R>W Variant assessed as Somatic; 0.0 impact. breast [NCI-TCGA, Cosmic] No ClinGen
cosmic curated
NCI-TCGA
TOPMed
gnomAD
rs758912519
CA4835048
648 S>R No ClinGen
ExAC
gnomAD
rs751676826
CA4835059
653 S>T No ClinGen
ExAC
gnomAD
rs996103644
CA182551602
654 P>S No ClinGen
gnomAD
rs558778118
CA4835061
657 D>G No ClinGen
ExAC
gnomAD
CA4835062
rs748009628
658 I>T No ClinGen
ExAC
TOPMed
gnomAD
TCGA novel 661 T>A Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA4835063
rs769718856
661 T>I No ClinGen
ExAC
gnomAD
rs749023962
CA4835065
662 G>S No ClinGen
ExAC
gnomAD
VAR_047442
CA4835067
rs12549394
664 A>E No ClinGen
UniProt
1000Genomes
ESP
ExAC
TOPMed
dbSNP
gnomAD
CA182551662
rs12549394
664 A>V No ClinGen
1000Genomes
ESP
ExAC
TOPMed
gnomAD
rs749101422
CA4835068
666 S>T No ClinGen
ExAC
TOPMed
gnomAD
rs777245445
CA4835070
669 L>S No ClinGen
ExAC
gnomAD
CA371627259
rs1279797675
670 Q>R No ClinGen
gnomAD
rs1376631182
CA371627276
671 V>I No ClinGen
TOPMed
rs970326057
CA182551671
672 P>T No ClinGen
TOPMed
CA4835073
rs773575339
677 P>L No ClinGen
ExAC
gnomAD
rs1418634189
CA371627365
677 P>T No ClinGen
TOPMed
CA371627385
rs1465708211
678 S>N Variant assessed as Somatic; 0.0 impact. [NCI-TCGA] No ClinGen
NCI-TCGA
gnomAD
CA4835074
rs763249133
678 S>R No ClinGen
ExAC
TOPMed
gnomAD
CA4835075
rs573163067
679 S>G No ClinGen
1000Genomes
ExAC
gnomAD
rs531823087
CA182551730
679 S>N No ClinGen
Ensembl
rs145137978
CA4835077
680 L>F No ClinGen
ESP
ExAC
TOPMed
gnomAD
CA4835076
rs145137978
680 L>I No ClinGen
ESP
ExAC
TOPMed
gnomAD
rs1001359011
CA182551784
681 K>R No ClinGen
TOPMed
gnomAD
CA371627455
rs1426821574
682 G>A No ClinGen
gnomAD
TCGA novel 682 G>R Variant assessed as Somatic; impact. [NCI-TCGA] No NCI-TCGA
CA4835078
rs767514175
683 S>F No ClinGen
ExAC
gnomAD
CA371627501
rs1345737229
687 L>F No ClinGen
gnomAD
rs1437140239
CA371627516
688 V>I No ClinGen
gnomAD
CA182551799
rs1035910686
690 P>L No ClinGen
TOPMed
gnomAD
CA371627598
rs1586533643
694 V>L No ClinGen
Ensembl
CA371627655
rs1275708078
698 Q>* No ClinGen
gnomAD
rs1347370815
CA371627657
698 Q>P No ClinGen
TOPMed
gnomAD
CA4835082
rs749153508
700 G>S No ClinGen
ExAC
TOPMed
gnomAD
CA371627697
rs1350106717
701 G>C No ClinGen
TOPMed
CA371627694
rs1350106717
701 G>S No ClinGen
TOPMed
CA371627700
rs1221924968
701 G>V No ClinGen
gnomAD
CA4835083
rs757112285
702 C>Y No ClinGen
ExAC
gnomAD
CA371627728
rs1563696331
703 H>R No ClinGen
Ensembl
rs771707817
CA4835087
707 T>C No ClinGen
ExAC
gnomAD
CA4835085
rs778666015
707 T>G No ClinGen
ExAC
gnomAD

2 associated diseases with O60353

[MIM: 161050]: Nail disorder, non-syndromic congenital, 1 (NDNC1)

An autosomal recessive nail disorder characterized by a variable degree of onychauxis (thick nails), hyponychia, and onycholysis of all nails, with claw-shaped fingernails in some individuals. No other anomalies of ectodermal tissues, including hair, teeth, sweat glands, or skin, are noted, and individuals with dysplastic nails have normal hearing and normal psychomotor development. {ECO:0000269|PubMed:21665003}. Note=The disease is caused by variants affecting the gene represented in this entry.

Without disease ID
  • An autosomal recessive nail disorder characterized by a variable degree of onychauxis (thick nails), hyponychia, and onycholysis of all nails, with claw-shaped fingernails in some individuals. No other anomalies of ectodermal tissues, including hair, teeth, sweat glands, or skin, are noted, and individuals with dysplastic nails have normal hearing and normal psychomotor development. {ECO:0000269|PubMed:21665003}. Note=The disease is caused by variants affecting the gene represented in this entry.

5 regional properties for O60353

Type Name Position InterPro Accession
domain Frizzled/Smoothened, transmembrane domain 188 - 513 IPR000539
domain GPCR, family 2-like, transmembrane domain 195 - 502 IPR017981
domain Frizzled domain 19 - 134 IPR020067
domain Frizzled-6, transmembrane domain 188 - 508 IPR026543
domain Frizzled 6, cysteine-rich domain 20 - 146 IPR041770

Functions

Description
EC Number
Subcellular Localization
  • Membrane ; Multi-pass membrane protein
  • Cell membrane ; Multi-pass membrane protein
  • Cell surface
  • Apical cell membrane; Multi-pass membrane protein
  • Cytoplasmic vesicle membrane ; Multi-pass membrane protein
  • Endoplasmic reticulum membrane ; Multi-pass membrane protein
  • Colocalizes with FZD3 at the apical face of cells (By similarity)
  • Localizes to the endoplasmic reticulum membrane in the presence of LMBR1L (By similarity)
PANTHER Family
PANTHER Subfamily
PANTHER Protein Class
PANTHER Pathway Category No pathway information available

8 GO annotations of cellular component

Name Definition
apical plasma membrane The region of the plasma membrane located at the apical end of the cell.
apicolateral plasma membrane The apical end of the lateral plasma membrane of epithelial cells.
cell surface The external part of the cell wall and/or plasma membrane.
cytoplasmic vesicle membrane The lipid bilayer surrounding a cytoplasmic vesicle.
endoplasmic reticulum membrane The lipid bilayer surrounding the endoplasmic reticulum.
integral component of membrane The component of a membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
integral component of plasma membrane The component of the plasma membrane consisting of the gene products and protein complexes having at least some part of their peptide sequence embedded in the hydrophobic region of the membrane.
plasma membrane The membrane surrounding a cell that separates the cell from its external environment. It consists of a phospholipid bilayer and associated proteins.

4 GO annotations of molecular function

Name Definition
G protein-coupled receptor activity Combining with an extracellular signal and transmitting the signal across the membrane by activating an associated G-protein; promotes the exchange of GDP for GTP on the alpha subunit of a heterotrimeric G-protein complex.
ubiquitin protein ligase binding Binding to a ubiquitin protein ligase enzyme, any of the E3 proteins.
Wnt receptor activity Combining with a Wnt protein and transmitting the signal across the plasma membrane to initiate a change in cell activity.
Wnt-protein binding Binding to a Wnt-protein, a secreted growth factor involved in signaling.

13 GO annotations of biological process

Name Definition
canonical Wnt signaling pathway The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes. In this pathway, the activated receptor signals via downstream effectors that result in the inhibition of beta-catenin phosphorylation, thereby preventing degradation of beta-catenin. Stabilized beta-catenin can then accumulate and travel to the nucleus to trigger changes in transcription of target genes.
cell proliferation in midbrain The multiplication or reproduction of cells, resulting in the expansion of a cell population in the midbrain.
embryonic nail plate morphogenesis The process, occurring in the embryo, by which the anatomical structures of a nail plate are generated and organized. The nail plate is the hard and translucent portion of the nail, composed of keratin, and serves to protect the tips of digits. [GOC:BHF, GOC:vk, ISBN:0323025781, PMID:11369996, UBERON:0008198, Wikipedia:Nail_(anatomy)]
establishment of body hair planar orientation Orientation of body hairs, projections from the surface of an organism, such that the hairs all point in a uniform direction along the surface.
hair follicle development The process whose specific outcome is the progression of the hair follicle over time, from its formation to the mature structure. A hair follicle is a tube-like opening in the epidermis where the hair shaft develops and into which the sebaceous glands open.
inner ear morphogenesis The process in which the anatomical structures of the inner ear are generated and organized. The inner ear is the structure in vertebrates that contains the organs of balance and hearing. It consists of soft hollow sensory structures (the membranous labyrinth) containing fluid (endolymph) surrounded by fluid (perilymph) and encased in a bony cavity (the bony labyrinth). It consists of two chambers, the sacculus and utriculus, from which arise the cochlea and semicircular canals respectively.
midbrain morphogenesis The developmental process by which a midbrain is generated and organized.
negative regulation of canonical Wnt signaling pathway Any process that decreases the rate, frequency, or extent of the Wnt signaling pathway through beta-catenin, the series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via beta-catenin, and ending with a change in transcription of target genes.
negative regulation of DNA-binding transcription factor activity Any process that stops, prevents, or reduces the frequency, rate or extent of the activity of a transcription factor, any factor involved in the initiation or regulation of transcription.
neural tube closure The last step in the formation of the neural tube, where the paired neural folds are brought together and fuse at the dorsal midline.
non-canonical Wnt signaling pathway The series of molecular signals initiated by binding of a Wnt protein to a frizzled family receptor on the surface of the target cell, followed by propagation of the signal via effectors other than beta-catenin.
platelet activation A series of progressive, overlapping events triggered by exposure of the platelets to subendothelial tissue. These events include shape change, adhesiveness, aggregation, and release reactions. When carried through to completion, these events lead to the formation of a stable hemostatic plug.
Wnt signaling pathway, planar cell polarity pathway The series of molecular signals initiated by binding of a Wnt protein to a receptor on the surface of the target cell where activated receptors signal via downstream effectors including C-Jun N-terminal kinase (JNK) to modulate cytoskeletal elements and control cell polarity.

23 homologous proteins in AiPD

UniProt AC Gene Name Protein Name Species Evidence Code
O19116 SFRP1 Secreted frizzled-related protein 1 Bos taurus (Bovine) PR
Q9DEQ4 SFRP1 Secreted frizzled-related protein 1 Gallus gallus (Chicken) PR
O57328 FZD1 Frizzled-1 Gallus gallus (Chicken) PR
Q9IA96 SFRP2 Secreted frizzled-related protein 2 Gallus gallus (Chicken) PR
O00144 FZD9 Frizzled-9 Homo sapiens (Human) PR
Q9ULW2 FZD10 Frizzled-10 Homo sapiens (Human) PR
Q8N474 SFRP1 Secreted frizzled-related protein 1 Homo sapiens (Human) PR
Q96HF1 SFRP2 Secreted frizzled-related protein 2 Homo sapiens (Human) PR
Q6FHJ7 SFRP4 Secreted frizzled-related protein 4 Homo sapiens (Human) PR
O75084 FZD7 Frizzled-7 Homo sapiens (Human) PR
Q14332 FZD2 Frizzled-2 Homo sapiens (Human) PR
Q9UP38 FZD1 Frizzled-1 Homo sapiens (Human) PR
Q9Z1N6 Sfrp4 Secreted frizzled-related sequence protein 4 Mus musculus (Mouse) PR
P97299 Sfrp2 Secreted frizzled-related protein 2 Mus musculus (Mouse) PR
Q8C4U3 Sfrp1 Secreted frizzled-related protein 1 Mus musculus (Mouse) PR
O70421 Fzd1 Frizzled-1 Mus musculus (Mouse) PR
Q9JIP6 Fzd2 Frizzled-2 Mus musculus (Mouse) PR
Q61090 Fzd7 Frizzled-7 Mus musculus (Mouse) PR
Q08463 Fzd1 Frizzled-1 Rattus norvegicus (Rat) PR
Q9JLS4 Sfrp4 Secreted frizzled-related protein 4 Rattus norvegicus (Rat) PR
Q08464 Fzd2 Frizzled-2 Rattus norvegicus (Rat) PR
Q7YRN1 SFRP4 Secreted frizzled-related protein 4 Macaca mulatta (Rhesus macaque) PR
Q5BL72 fzd7 Frizzled-7 Xenopus tropicalis (Western clawed frog) (Silurana tropicalis) PR
10 20 30 40 50 60
MEMFTFLLTC IFLPLLRGHS LFTCEPITVP RCMKMAYNMT FFPNLMGHYD QSIAAVEMEH
70 80 90 100 110 120
FLPLANLECS PNIETFLCKA FVPTCIEQIH VVPPCRKLCE KVYSDCKKLI DTFGIRWPEE
130 140 150 160 170 180
LECDRLQYCD ETVPVTFDPH TEFLGPQKKT EQVQRDIGFW CPRHLKTSGG QGYKFLGIDQ
190 200 210 220 230 240
CAPPCPNMYF KSDELEFAKS FIGTVSIFCL CATLFTFLTF LIDVRRFRYP ERPIIYYSVC
250 260 270 280 290 300
YSIVSLMYFI GFLLGDSTAC NKADEKLELG DTVVLGSQNK ACTVLFMLLY FFTMAGTVWW
310 320 330 340 350 360
VILTITWFLA AGRKWSCEAI EQKAVWFHAV AWGTPGFLTV MLLAMNKVEG DNISGVCFVG
370 380 390 400 410 420
LYDLDASRYF VLLPLCLCVF VGLSLLLAGI ISLNHVRQVI QHDGRNQEKL KKFMIRIGVF
430 440 450 460 470 480
SGLYLVPLVT LLGCYVYEQV NRITWEITWV SDHCRQYHIP CPYQAKAKAR PELALFMIKY
490 500 510 520 530 540
LMTLIVGISA VFWVGSKKTC TEWAGFFKRN RKRDPISESR RVLQESCEFF LKHNSKVKHK
550 560 570 580 590 600
KKHYKPSSHK LKVISKSMGT STGATANHGT SAVAITSHDY LGQETLTEIQ TSPETSMREV
610 620 630 640 650 660
KADGASTPRL REQDCGEPAS PAASISRLSG EQVDGKGQAG SVSESARSEG RISPKSDITD
670 680 690 700
TGLAQSNNLQ VPSSSEPSSL KGSTSLLVHP VSGVRKEQGG GCHSDT